N-of-1 trials are the gold standard study design to evaluate individual treatment effects and derive personalized treatment strategies. Digital tools have the potential to initiate a new era of N-of-1 trials in terms of scale and scope, but fully-functional platforms are not yet available. Here, we present the open source StudyU platform which includes the StudyU designer and StudyU app. With the StudyU designer, scientists are given a collaborative web application to digitally specify, publish, and conduct N-of-1 trials. The StudyU app is a smartphone application with innovative user-centric elements for participants to partake in the published trials and assess the effects of different interventions on their health. Thereby, the StudyU platform allows clinicians and researchers worldwide to easily design and conduct digital N-of-1 trials in a safe manner. We envision that StudyU can change the landscape of personalized treatments both for patients and healthy individuals, democratize and personalize evidence generation for self-optimization and medicine, and can be integrated in clinical practice.
翻译:Nof-1试验是评估个人治疗效果和制定个性化治疗战略的金质标准研究设计; 数字工具有可能在规模和范围方面启动Nof-1试验的新时代,但尚不具备完全运作的平台; 在这里,我们介绍开放源的研究U平台,其中包括研究U设计者和研究U应用软件; 与研究U设计者一起,科学家们获得一个协作的网络应用程序,以数字方式指定、公布和进行N-of-1试验; 研究U应用是一种智能手机应用程序,具有创新的用户中心要素,参与者可以参与已出版的试验,并评估各种干预措施对其健康的影响; 研究U平台使世界各地的临床医生和研究人员能够以安全的方式方便地设计和进行数字Nof-1试验; 我们设想研究U可以改变病人和健康个人个人个性化治疗的格局,为自我优化和医学实现民主化和个性化证据生成,并被纳入临床实践。